Skye Bioscience, Inc.

Skye Bioscience, Inc.

SKYE · Nasdaq

Skye Bioscience, Inc. (SKYE) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Skye Bioscience, Inc. in 2026. The next earnings report is expected on November 5, 2026.

Earnings calendar

Next earnings date

05 Nov 2026

In 77 days

EPS estimate

-0.21

Revenue estimate

0

Past earnings

14 Aug 2026
EPS actual
-0.15 (+41.2%)
estimate -0.25
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
11 May 2026
EPS actual
-0.32 (-3.7%)
estimate -0.31
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
10 Mar 2026
EPS actual
-0.36 (-21.2%)
estimate -0.30
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Latest earnings analysis

Skye Bioscience, Inc. beat consensus estimates in its latest earnings report, with EPS of $-0.1498 versus an estimate of $-0.255 and revenue of $0 that met expectations. In the prior quarter EPS missed expectations while revenue met estimates.

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

Skye Bioscience, Inc., a biopharmaceutical company, discovers, develops, and commercializes cannabinoid-based molecules for the treatment of infectious diseases. The company's lead product candidate is SBI-100, which is in Phase I trials for the treatment of glaucoma and ocular hypertension. It is also developing SBI-200 that is in preclinical trials to treat and manage various eye diseases, including uveitis, dry eye syndrome, macular degeneration and diabetic retinopathy. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc. was founded in 2012 and is headquartered in San Diego, California.

Sector
Healthcare
Industry
Biotechnology
Country
United States
Exchange
Nasdaq
CEO
Punit S. Dhillon
Employees
16
IPO date
26 Nov 2014
ISIN
US83086J2006
Website
skyebioscience.com

Frequently asked questions

When does Skye Bioscience, Inc. (SKYE) next report earnings?

Skye Bioscience, Inc. (SKYE) is scheduled to report earnings on November 5, 2026.

What was Skye Bioscience, Inc.'s most recent earnings date?

Skye Bioscience, Inc. (SKYE) last reported earnings on August 14, 2026.

Where is Skye Bioscience, Inc. stock listed?

Skye Bioscience, Inc. (SKYE) is listed on Nasdaq.